Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β₂ Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Shih-Lung Cheng1 Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;2 Department of Chemical Engineering and Materials Science, Yuan-Ze University, Taoyuan, Taiwan

Ming-Lin Ho3 Division of Chest Medicine, Kuang Tien General Hospital, Taichung, Taiwan

Yun-Fa Lai4 Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan

Hao-Chien Wang5 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Jeng-Yuan Hsu6 Division of Clinical Research, Taichung Veterans General Hospital, Taichung, Taiwan

https://orcid.org/0000-0001-9553-1717

Shih-Feng Liu7 Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan;8 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Ming-Shyang Huang9 Department of Internal Medicine, E-DA Cancer Hospital and Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

https://orcid.org/0000-0002-4342-8969

Cheng-Hung Lee10 Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Ching-Hsiung Lin3 Division of Chest Medicine, Kuang Tien General Hospital, Taichung, Taiwan;11 Division of Chest Medicine, Changhua Christian Hospital, Changhua, Taiwan

Liang-Wen Hang12 School of Nursing & Graduate Institute of Nursing, China Medical University, Taichung, Taiwan;13 Sleep Medicine Center, China Medical University Hospital, Taichung, Taiwan

https://orcid.org/0000-0003-3237-5491

Yu-Chih Liu14 Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan

Kuang-Yao Yang15 Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;16 Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang-Ming University, Taipei, TaiwanCorrespondence[email protected] [email protected]

https://orcid.org/0000-0002-2803-980X

Jia-Horng Wang14 Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan;17 Hyperbaric Oxygen Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β₂ Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β₂ Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study